M

Moderna

Develops mRNA-based medicines for health

Director Analytical Chemistry

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeCambridge, MA, USAIn-person

About the Job

Requirements

  • A Ph.D. in Analytical Chemistry, Organic Chemistry, Pharmaceutical Sciences, Chemical Biology, Chemical Engineering, or a closely related discipline, with 9 or more years of relevant industry experience; a strong M.S. candidate with significant leadership experience may also be considered.
  • Substantial experience in analytical chemistry supporting discovery research and/or early development in biotech or pharmaceutical settings, including demonstrated leadership at the program, function, or platform level.
  • Deep expertise in small molecules, polymers, and lipid analytical chemistry, including structure elucidation, impurity assessment, method development, advanced characterization, and orthogonal analytical approaches and tools for novel chemical entities or excipients.
  • Deep expertise in separation techniques and analytical platforms such as ultra-performance liquid chromatography, high-performance liquid chromatography, liquid chromatography-mass spectrometry, liquid chromatography-charged aerosol detection, gas chromatography-mass spectrometry, capillary electrophoresis, nuclear magnetic resonance, ultraviolet-visible spectroscopy, infrared spectroscopy, particle or colloidal characterization methods, and other relevant physicochemical and spectroscopic techniques.
  • Working knowledge of large molecule and nucleic acid analytics, including meaningful familiarity with mRNA or related RNA characterization and an understanding of how RNA quality attributes interface with formulation and delivery performance.
  • Demonstrated managerial abilities and strong technical leadership in direct reporting relationships and in matrix and cross-functional environments to execute strategy.
  • Experience with technology transfer to internal or external partners and productive working relationships with contract research organizations and/or contract development and manufacturing organizations.
  • Experience developing phase-appropriate analytical strategies and control concepts in settings bridging discovery and development, including familiarity with technical documentation that supports progression into regulated environments.
  • Sound understanding of analytical methods pertaining to mRNA-lipid nanoparticle products and their components, including relationships between lipid identity, composition, formulation properties, and product performance.
  • Familiarity with electronic laboratory notebooks, chromatography data systems, laboratory execution systems, and/or laboratory information management systems, and interest in modern data workflows that improve decision-making and execution speed.
  • Experience applying high-throughput methodologies to accelerate research and development, and proficiency in leveraging artificial intelligence and machine learning to enhance data analysis and inform decision-making.
  • Ability to distill complex analytical data into clear recommendations for senior leaders and diverse scientific stakeholders.
  • Ability to drive teams toward best practices in a fast-paced environment while helping build durable technical and business processes.
  • The position is site-based, requires full-time attendance at Moderna’s site, and is not eligible for remote work.
  • Only individuals who qualify as U.S. persons (citizens, permanent residents, asylees, or refugees) are eligible because of export-control requirements.

Responsibilities

  • Lead and develop a high-performing team of analytical scientists and, depending on organizational design, matrix-lead additional scientists across analytical chemistry, characterization, and platform functions supporting discovery-stage mRNA-lipid nanoparticle research.
  • Set the analytical chemistry vision and strategy for discovery-stage mRNA-lipid nanoparticle programs, ensuring fit-for-purpose analytical capabilities support lipid design, payload evaluation, formulation screening, and candidate advancement.
  • Serve as the senior analytical partner to medicinal chemistry teams by enabling structure confirmation, purity and impurity profiling, route support, reference standard strategy, and rapid troubleshooting for novel lipids and related small molecules.
  • Partner with computational chemistry and data science teams to translate molecular design hypotheses into analytical learning plans, generate datasets that improve structure-property understanding, and inform iterative design of ionizable lipids and related delivery materials.
  • Collaborate with formulation and delivery sciences teams to establish analytical workflows for screening and characterizing lipid nanoparticle systems, including lipid composition assessment, encapsulation-related analytics, degradation pathways, and physicochemical attribute characterization.
  • Guide fit-for-purpose analytical method development, optimization, qualification, transfer, and lifecycle management across chromatography, mass spectrometry, spectroscopy, and orthogonal characterization platforms.
  • Provide scientific leadership in small molecule and lipid structure elucidation, impurity identification, forced degradation or stress studies where relevant, and root-cause analysis of analytical or material quality issues.
  • Oversee analytical characterization strategies for relevant large molecules and nucleic acid components, with familiarity in mRNA or related RNA analytics and the interfaces between drug substance, formulation, and drug product performance.
  • Work with discovery, platform, and selected development teams to ensure analytical deliverables, technical risk assessments, and timelines remain aligned with program objectives and portfolio milestones.
  • Provide technical leadership and oversight to external partners, including contract research organizations and contract development and manufacturing organizations, for specialty characterization, method transfer, development support, and data package review.
  • Author and review technical reports, analytical development documentation, invention disclosures, publications, and selected regulatory-facing analytical content as appropriate for program maturity.
  • Serve as a strategic and technical partner to Research, Technical Development, Analytical Development, and Process Chemistry and Development functions to drive analytical strategy discussions, define action items, and build scalable capabilities where discovery and development intersect.
  • Represent analytical chemistry in cross-functional governance, portfolio discussions, technical reviews, and external interactions, and help shape investment priorities for instrumentation, digital workflows, and scientific capability building.
  • Apply high-throughput methodologies to accelerate research and development efforts, leveraging artificial intelligence and machine learning techniques to enhance data analysis and decision-making.
  • Liaise with the appropriate teams and groups in the centers-of-emphasis model to lead technical and strategic efforts in small molecule, lipid, RNA, and nanoparticle analytics.

Desired Qualifications

  • Experience supporting mRNA-lipid nanoparticle, oligonucleotide, gene editing, or related nucleic acid modalities in discovery, translational, or early development settings.
  • Experience with lipid library characterization, ionizable lipid structure-property relationships, and analytical support for high-throughput or iterative formulation screening workflows.
  • Experience contributing to IND-enabling or early clinical development programs, including analytical sections of technical reports, regulatory submissions, or health authority responses.
  • Familiarity with design-of-experiments, multivariate data analysis, cheminformatics-enabled workflows, and digital laboratory systems.
  • Experience with high-throughput methodologies and familiarity with artificial intelligence and machine learning techniques.
  • A publication, patent, or innovation record demonstrating scientific thought leadership in analytical chemistry, delivery sciences, or nucleic acid therapeutics.

About the Company

Moderna

Develops mRNA-based medicines for health

Moderna develops medicines built on messenger RNA (mRNA). Its products use mRNA delivered into cells to instruct them to produce specific proteins that can prevent or treat disease, with vaccines being a primary example. In practice, a dose delivers engineered mRNA into the body, cells translate it into a target protein, and the immune system responds or the protein modulates biology to combat disease. Moderna differentiates itself through its focus on building a whole mRNA medicines platform and in-house capabilities for designing, manufacturing, and scaling mRNA therapies, including rapid development and large-scale production. Its goal is to create a new category of medicines based on mRNA that can improve how diseases are discovered, developed, and treated, ultimately improving patient outcomes.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2010

Recently Posted Jobs

Explore more opportunities at Moderna

See more jobs